ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions
Abstract
Although numerous studies have addressed the safety and effectiveness of hormonal contraceptive use in healthy women, data regarding women with underlying medical conditions or other special circumstances are limited. The U.S. Medical Eligibility Criteria (USMEC) for Contraceptive Use , 2016 (1), which has been endorsed by the American College of Obstetricians and Gynecologists, is a published guideline based on the best available evidence and expert opinion to help health care providers better care for women with chronic medical problems who need contraception. The goal of this Practice Bulletin is to explain how to use the USMEC rating system in clinical practice and to specifically discuss the rationale behind the ratings for various medical conditions. Contraception for women with human immunodeficiency virus (HIV) (2); the use of emergency contraception in women with medical coexisting medical conditions, including obesity, (3); and the effect of depot medroxyprogesterone acetate (DMPA) on bone health (4) are addressed in other documents from the American College of Obstetricians and Gynecologists.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The ACOG 2019 guidelines considers CHC use with any hereditary thrombophilia to be contraindicated.
“Based on this, the ACOG 2019 guidelines considers CHC use with any hereditary thrombophilia to be contraindicated [113].”
From Estrogen and thrombosis: a bench to bedside review (2020) · cites this paper as [113]
The citation lists haven’t been fetched yet
References 194 · Cited by 147
- Venue
- Obstetrics & Gynecology
- Published
- 2019-02
- Volume
- 133
- Issue
- 2
- Pages
- e128-e150
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W4210973869
- Semantic Scholar
- b4c2d6dacc34290fe190390756b88098b4af623c
- Cited by
- 147
- References
- 194
- Citations by year
- 2026: 25 · 2025: 26 · 2024: 18 · 2023: 16 · 2022: 21 · 2021: 9 · 2020: 23 · 2019: 7
- FWCI
- 13.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Social Sciences › Political Science and International Relations › International Human Rights and Reproductive Law
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- hormonal contraception, medical eligibility criteria, HIV, emergency contraception, obesity, depot medroxyprogesterone acetate, bone health, contraceptive safety
- MeSH terms
- Contraindications, Drug, Contraceptives, Oral, Hormonal, Female, Humans, Postpartum Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
